Archive for the ‘Respiratory / Asthma’ Category

Scientist Discovers Clue In Mysterious Lung Disease

Thursday, November 1st, 2007

Even though it affects more than 5 million people world-wide,* pulmonary fibrosis remains a mysterious and incurable disease. A recent discovery could someday change that. Researchers have uncovered a clue as to how this devastating lung disease is formed, and how they might try to stop it. He may not be ...

Simple Strategy Could Prevent Half Of Deadly Tuberculosis Infections

Thursday, November 1st, 2007

By using a combination of inexpensive infection control measures, hospitals around the world could prevent half the new cases of extensively drug resistant tuberculosis (XDR TB), according to a new study in The Lancet by researchers at Yale School of Medicine. Dubbed "Ebola With Wings" for its ability to spread and ...

MedImmune Presents New Pharmaco-Economic Data At American Academy Of Pediatrics Regarding Infants At High Risk For RSV

Wednesday, October 31st, 2007

MedImmune announced results from a recent economic analysis of Synagis(R) (palivizumab), a monoclonal antibody (MAb) that is the standard of care for prevention of severe lower respiratory tract infection due to respiratory syncytial virus (RSV) in high- risk infants. Released at the American Academy of Pediatrics (AAP) 2007 National Conference ...

Grant Funds Research On Inflammation, Kidney Disease And Cardiovascular Disease, USA

Friday, October 26th, 2007

University of Texas Medical Branch at Galveston researcher Thomas P. Erlinger has received a two-year $408,000 grant from the National Institute of Diabetes and Digestive and Kidney Diseases to advance his research on inflammation, kidney disease progression and incident cardiovascular disease. Chronic kidney disease and atherosclerotic cardiovascular disease share common antecedents, ...

Results Of Clinical Trials Of Nebulized Formoterol Fumarate: Long-term And Cardiovascular Safety COPD

Thursday, October 25th, 2007

Data from two Phase III clinical trials were presented in Chicago at CHEST 2007, the annual scientific assembly of the American College of Chest Physicians (ACCP), supporting the use of Perforomistâ„¢ (formoterol fumarate) Inhalation Solution as a safe and effective maintenance treatment for COPD patients. The results of both studies ...

Results Of Clinical Trial For Safety/Efficacy Of Concomitant Formoterol Fumarate/Tiotropium Treating COPD

Thursday, October 25th, 2007

Data presented at CHEST 2007, the annual scientific assembly of the American College of Chest Physicians (ACCP), demonstrate concomitant use of nebulized formoterol fumarate and tiotropium provided improved bronchodilation over tiotropium monotherapy and was well-tolerated in this clinical study. The only commercially available version of nebulized formoterol fumarate is Perforomistâ„¢ ...

Asthma Inhalers Go CFC-Free, Australia

Monday, October 22nd, 2007

The National Asthma Council Australia has welcomed the news that Australia's last CFC asthma inhaler, Serevent Metered Dose Inhaler, will be discontinued from December 31, 2007. According to the Council, which led the charge for the discontinuation of CFC containing inhalers, the phasing out of CFCs in asthma inhalers has been ...

AAAAI: Early Day Care Attendance May Protect Infants From Later Developing Asthma, From The Journal Of Allergy And Clinical Imm

Tuesday, October 16th, 2007

Day care attendance early in life seems to protect infants and young children from later developing asthma, from the Journal of Allergy and Clinical Immunology (JACI). The study, "Influence of early day care exposure on total IgE levels through age 3 years" can be found in the Articles ...

Choline, An Alternative Therapy For Asthma

Friday, September 28th, 2007

The prevalence of asthma has increased worldwide and current therapies for the disease, such as glucocorticoids, are limited in their usefulness, due to potential side effects. Bhanu Pratap Singh (Allergy and Immunology Section, Institute of Genomics and Integrative Biology, Delhi, India) and his team examined the anti-inflammatory effects of choline via ...